Blog
Exploring Cell Mechanics – From Ripe Avocados to Sepsis Diagnosis
BlogIn this interview, Daniel Klaue explains why it is important to measure cell mechanics, discusses a novel method of doing so, and highlights how this technology could benefit clinical applications.
Read More
A Step Closer to a Bioengineered Liver Fit for Transplantation
BlogIn a study recently published in Nature Biomedical Engineering, bioengineered livers created by decellularization and recellularization were implanted into pigs, where they were able to sustain continuous perfusion for up to 15 days. We spoke to Miromatrix’s CEO, Dr Jeff Ross, to learn more about the study and how it advances the state of bioengineering organs.
Read More
Collaboration Is the X Factor in Making Precision Medicine a Success
BlogCompanion diagnostics (CDx), i.e. in vitro medical devices, and next-generation sequencing (NGS), are both essential to the practice of precision medicine. As new regulations are introduced, pharma companies and manufacturers alike need to ensure their CDx processes are compliant or we could see a deceleration in the flow of new precision therapies in the near future.
Read More
Synthesis Innovation in Drug Discovery
BlogWe recently had the pleasure of speaking with Danica Rankic, Associate Principal Scientist, MSD to learn more about their process chemistry activities. She touches on the synthesis strategies impacting drug discovery and provides a snapshot of her upcoming talk, taking place December, 2019.
Read More
Next-generation Sequencing Advancements in the Diagnostic Lab
BlogAgilent are working to increase the utility of NGS in the diagnostics field and in personalized medicine. We recently spoke with Ronda Allen, Head of R&D at Agilent, to learn more about two of Agilent's newest products in this space, the Cancer All-in-one (AIO) panels, and the Magnis NGS Library Prep System.
Read More
Speed, Sensitivity, and High-throughput Analysis: The Latest Advancements in Metabolomics
BlogTo find out more about the recent advances in metabolomics and the technologies that have evolved alongside it, we spoke with Lucy Woods, Global Technology Leader at Bruker Daltonics.
Read More
Fuelling Innovation in UK Life Sciences
BlogWe spoke to Daniel Rooke, Head of Operations and Legal at Start Codon, to learn more about the company and how they can help early stage healthcare and life science businesses in the UK to get off the ground.
Read More
Therapeutically Targeting the Interconnected Biology of the Gut
BlogWe recently had the pleasure of interviewing Paul-Peter Tak, CEO of Kintai Therapeutics. Tak discusses how Kintai Therapeutics are exploiting the power of big data and machine learning to unravel the interconnected biology of the gut, and explains how the enteric signaling network can be therapeutically targeted.
Read More
Easing the "Informatics Bottleneck" Burden in Next-generation Sequencing
BlogTechnology Networks recently spoke with Rosengarten and Raymond Mercier, VP and GM, Molecular Biology, Thermo Fisher Scientific, to learn more about how the co-marketing agreement between Thermo Fisher Scientific and Genialis will help ease the burden of the "informatics bottleneck" for research scientists.
Read More
Analyzing Sperm DNA Damage To Diagnose Male Infertility
BlogA recent collaborative study between Examen and the Lister Fertility Clinic in London used Examen’s COMET assay to measure sperm DNA damage in men with unexplained infertility. We spoke with Professor Sheena Lewis, CEO of Examen, to learn more about the study, the links between sperm DNA damage and infertility, and the value of adding this parameter to fertility testing.
Read More
